You are about to action:

Object being modified by the action

Do you want to proceed?

Share Video Link

https://www.bitchute.com/video/HjXfpiabG7xG/

Click to copy, then share by pasting into your messages, comments, social media posts and websites.

Embed Video HTML

Click to copy, then add into your webpages so users can view and engage with this video from your site.

Share to Social Media

Share to social media by clicking on the quick share links.

Reason

Please select the most appropriate reason from the list provided.

Note: For a more detailed description of each reason, see our Community Guidelines.

Additional Comments

Please add any additonal comments that will help with the assessment of your request.

Note: Copyright claims must contain all the items specified within the Copyright Policy.

Email Submissions

We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.

We will investigate and take the appropriate action.

Add to Playlist

Davos 2015 - Rewriting Human Genes

Next video playing soon

Click to cancel

Autoplay has been paused

Click to watch next video

First published at 09:46 UTC on August 16th, 2023.

subscribers

BitChute Advertisement

Davos 2015 - Rewriting Human Genes
https://youtu.be/p-t5VrCtY1Q
.
Davos 2015 - Rewriting Human Genes
https://rumble.com/v3842vd-davos-2015-rewriting-human-genes.html
.
Tal Zaks, the Chief Medical Officer of Moderna: "Hacking the software of life.&qu…

Moderna: "Hacking the software of life."
(PAGE REMOVED) https://www.modernatx.com/mrna-technology/mrna-platform-enabling-drug-discovery-development
THANK GOD FOR THE WAYBACK MACHINE:
http://web.archive.org/web/20201116152329/https://www.modernatx.com/mrna-technology/mrna-platform-enabling-drug-discovery-development
.
PFIZER:
"mRNA technology is a good fit for gene editing. We want to make these editing proteins for just a short period of time to modify the genome. And producing the editing enzymes transiently helps to reduce the potential for off-target effects."
Seng Cheng, Vice President and Chief Scientific Officer of the Rare Disease Research Unit at Pfizer.
https://rumble.com/v37ir8i-august-14-2023.html

LESS